Insider Trades
News
globenewswire.comCocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officerglobenewswire.comJun 3
globenewswire.comCocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officerglobenewswire.comJun 3
globenewswire.comCocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenzaglobenewswire.comMay 26
globenewswire.comCocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Resultsglobenewswire.comMay 15
globenewswire.comCocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infectionglobenewswire.comApr 30